UBS upgrades Bayer to “buy,” sets €52 target on glyphosate settlement progress

Investing.com Gold reports: UBS upgrades Bayer to “buy,” sets €52 target on glyphosate settlement progress. This is a premium/paywalled source, so the brief is based on headline and available metadata only.